The global market for Biosimulation Technology is estimated at US$2.7 Billion in 2023 and is projected to reach US$7.6 Billion by 2030, growing at a CAGR of 15.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Biosimulation Technology Market]( "Biosimulation Technology Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Biosimulation Software segment, which is expected to reach US$5.1 Billion by 2030 with a CAGR of 14.8%. The Biosimulation Services segment is also set to grow at 17.4% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $815.8 Million in 2023, and China, forecasted to grow at an impressive 14.5% CAGR to reach $1.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biosimulation Technology Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biosimulation Technology Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biosimulation Technology Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 3DS BIOVIA, Advanced Chemistry Development, Inc. (ACD/Labs), Certara USA, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 22 Featured):
- 3DS BIOVIA
- Advanced Chemistry Development, Inc. (ACD/Labs)
- Certara USA, Inc.
- Genedata AG
- Schrodinger LLC
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Biosimulation Technology - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Biosimulation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 2: World 7-Year Perspective for Biosimulation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 4: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 6: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 8: World 7-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 10: World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 12: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Regulatory Authorities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 14: World 7-Year Perspective for Regulatory Authorities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Academic Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 16: World 7-Year Perspective for Academic Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 18: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 20: World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
- Table 21: World Biosimulation Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 22: USA Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 23: USA 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 24: USA Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 25: USA 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 27: USA 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
CANADA
- Table 28: Canada Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 29: Canada 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 30: Canada Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 31: Canada 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 33: Canada 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
JAPAN
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 34: Japan Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 35: Japan 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 36: Japan Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 37: Japan 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: Japan 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
CHINA
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 40: China Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 41: China 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 42: China Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 43: China 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: China 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
EUROPE
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 46: Europe Recent Past, Current & Future Analysis for Biosimulation Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 47: Europe 7-Year Perspective for Biosimulation Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
- Table 48: Europe Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 49: Europe 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: Europe 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 52: Europe Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 53: Europe 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
FRANCE
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 54: France Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 55: France 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 56: France Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: France 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 58: France Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 59: France 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
GERMANY
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 60: Germany Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 61: Germany 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 62: Germany Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 63: Germany 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 64: Germany Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 65: Germany 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
ITALY
- Table 66: Italy Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 67: Italy 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 68: Italy Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: Italy 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 70: Italy Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 71: Italy 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
UNITED KINGDOM
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 72: UK Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 73: UK 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 74: UK Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: UK 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 76: UK Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 77: UK 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
REST OF EUROPE
- Table 78: Rest of Europe Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 79: Rest of Europe 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: Rest of Europe 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 82: Rest of Europe Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 83: Rest of Europe 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
ASIA-PACIFIC
- Biosimulation Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 85: Asia-Pacific 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: Asia-Pacific 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 89: Asia-Pacific 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
REST OF WORLD
- Table 90: Rest of World Recent Past, Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 91: Rest of World 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2024 & 2030
- Table 92: Rest of World Recent Past, Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of World 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2024 & 2030
- Table 94: Rest of World Recent Past, Current & Future Analysis for Biosimulation Technology by End-Use - Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 95: Rest of World 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, Academic Research Institutions and Regulatory Authorities for the Years 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3DS BIOVIA
- Advanced Chemistry Development, Inc. (ACD/Labs)
- Certara USA, Inc.
- Genedata AG
- Schrodinger LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 214 |
| Published | May 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.7 Billion |
| Forecasted Market Value ( USD | $ 7.6 Billion |
| Compound Annual Growth Rate | 15.6% |
| Regions Covered | Global |
